Denied

No. 11-1078

GlaxoSmithKline v. Classen Immunotherapies, Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.

Supplemental brief of petitioner GlaxoSmithKline filed. (Distributed)

DISTRIBUTED for Conference of January 11, 2013.

Brief amicus curiae of United States filed.

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

DISTRIBUTED for Conference of June 21, 2012.

Reply of petitioner GlaxoSmithKline filed.

Brief of respondent Classen Immunotherapies, Inc. in opposition filed.

Response Requested . (Due May 23, 2012)

DISTRIBUTED for Conference of May 10, 2012.

Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.

Petition for a writ of certiorari filed. (Response due April 2, 2012)

Parties

GlaxoSmithKline, Petitioner, represented by Carter G. Phillips

Classen Immunotherapies, Inc., Respondent, represented by Joseph J. Zito

Amici Curiae

Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Harry J. Roper

United States, Amicus Curiae, represented by Donald B. Verrilli Jr.

 
Last updated: February 16, 2016